Literature DB >> 12867210

Nicotine and drug interaction expectancies among methadone maintained cigarette smokers.

Michael D Stein1, Bradley J Anderson.   

Abstract

Smoking rates among persons being treated with methadone for opiate dependence are exceptionally high. Nevertheless, there is debate about whether smoking cessation has a negative effect on substance abuse treatment outcomes. To understand patient perceptions of the interaction between smoking and illicit drug use, we administered the Nicotine and Other Substances Interaction Expectancies questionnaire (NOSIE) to 168 smokers-79% Caucasian and 48% female-at two methadone programs in Providence, Rhode Island. The four summed-rating scales of this 20-item instrument exhibited good to excellent internal-consistency reliabilities. The scales measured the effect of drug use on smoking (5 items, alpha =.84), the effect of smoking on drug use (3 items, alpha =.73), smoking to cope with drug urges (9 items, alpha =.91), and the difficulty of concomitantly quitting smoking and drugs (3 items, alpha =.72).Most subjects believed drug use increased smoking, but that smoking did not trigger drug use. Relatively few reported smoking to cope with drug urges and most did not consider quitting smoking and quitting drug use to be incompatible goals. NOSIE was a reliable instrument that offers insight into patient expectations of the interaction of smoking and drug use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867210     DOI: 10.1016/s0740-5472(03)00030-8

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  8 in total

1.  Marijuana use and tobacco smoking cessation among heavy alcohol drinkers.

Authors:  Jane Metrik; Nichea S Spillane; Adam M Leventhal; Christopher W Kahler
Journal:  Drug Alcohol Depend       Date:  2011-07-02       Impact factor: 4.492

2.  An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste Caviness; Kristin Grimone; Daniel Audet; Bradley J Anderson; Genie L Bailey
Journal:  Nicotine Tob Res       Date:  2015-12-28       Impact factor: 4.244

3.  Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment.

Authors:  Nina A Cooperman; Kimber P Richter; Steven L Bernstein; Marc L Steinberg; Jill M Williams
Journal:  Subst Use Misuse       Date:  2015-01-05       Impact factor: 2.164

4.  Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Authors:  Carrie Reed; Caleb Bliss; Sherri O Stuver; Timothy Heeren; Sheila Tumilty; C Robert Horsburgh; Jeffrey H Samet; Deborah J Cotton
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

5.  Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Authors:  Amit Chakrabarti; George E Woody; Margaret L Griffin; Geetha Subramaniam; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

6.  Effects of tobacco on affect and craving during opioid addiction recovery: An ecological momentary assessment study.

Authors:  Blythe E Rhodes; Nisha C Gottfredson
Journal:  Addict Behav       Date:  2020-02-17       Impact factor: 3.913

Review 7.  Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings.

Authors:  Sharon M Hall; Judith J Prochaska
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

8.  Respiratory symptom relief related to reduction in cigarette use.

Authors:  Michael D Stein; Marjorie C Weinstock; Debra S Herman; Bradley J Anderson
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.